Global mRNA Vaccines and mRNA Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global mRNA Vaccines and mRNA Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
mRNA Vaccines and mRNA Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global mRNA Vaccines and mRNA Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Infectious Disease and Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for mRNA Vaccines and mRNA Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, mRNA Vaccines and mRNA Drugs key manufacturers include Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, eTheRNA, Takara Bio Inc., Sangamo Therapeutics and Roche CustomBiotech, etc. Thermo Fisher, Merck, Qiagen N.V. are top 3 players and held % sales share in total in 2022.
mRNA Vaccines and mRNA Drugs can be divided into Vaccine and API, etc. Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
mRNA Vaccines and mRNA Drugs is widely used in various fields, such as Infectious Disease and Cancer, etc. Infectious Disease provides greatest supports to the mRNA Vaccines and mRNA Drugs industry development. In 2022, global % sales of mRNA Vaccines and mRNA Drugs went into Infectious Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global mRNA Vaccines and mRNA Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Thermo Fisher
Merck
Qiagen N.V.
CureVac
In-Cell-Art
eTheRNA
Takara Bio Inc.
Sangamo Therapeutics
Roche CustomBiotech
BioNTech
Tiba Biotechnology
TriLink Bio Technologies
Argos Therapeutics
Moderna Therapeutics
NEB
Ethris
Aldevron
Promega
Translate Bio
Segment by Type
Vaccine
API
Infectious Disease
Cancer
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the mRNA Vaccines and mRNA Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of mRNA Vaccines and mRNA Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the mRNA Vaccines and mRNA Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of mRNA Vaccines and mRNA Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, mRNA Vaccines and mRNA Drugs introduction, etc. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of mRNA Vaccines and mRNA Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for mRNA Vaccines and mRNA Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, mRNA Vaccines and mRNA Drugs key manufacturers include Thermo Fisher, Merck, Qiagen N.V., CureVac, In-Cell-Art, eTheRNA, Takara Bio Inc., Sangamo Therapeutics and Roche CustomBiotech, etc. Thermo Fisher, Merck, Qiagen N.V. are top 3 players and held % sales share in total in 2022.
mRNA Vaccines and mRNA Drugs can be divided into Vaccine and API, etc. Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
mRNA Vaccines and mRNA Drugs is widely used in various fields, such as Infectious Disease and Cancer, etc. Infectious Disease provides greatest supports to the mRNA Vaccines and mRNA Drugs industry development. In 2022, global % sales of mRNA Vaccines and mRNA Drugs went into Infectious Disease filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global mRNA Vaccines and mRNA Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Thermo Fisher
Merck
Qiagen N.V.
CureVac
In-Cell-Art
eTheRNA
Takara Bio Inc.
Sangamo Therapeutics
Roche CustomBiotech
BioNTech
Tiba Biotechnology
TriLink Bio Technologies
Argos Therapeutics
Moderna Therapeutics
NEB
Ethris
Aldevron
Promega
Translate Bio
Segment by Type
Vaccine
API
Segment by Application
Infectious Disease
Cancer
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the mRNA Vaccines and mRNA Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of mRNA Vaccines and mRNA Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the mRNA Vaccines and mRNA Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of mRNA Vaccines and mRNA Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, mRNA Vaccines and mRNA Drugs introduction, etc. mRNA Vaccines and mRNA Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of mRNA Vaccines and mRNA Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices